
Intellia Therapeutics NTLA
$ 7.11
-11.9%
Annual report 2024
added 02-27-2025
Country |
![]() |
IPO year |
2016 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
98.8 M |
Market Cap[1] |
$ 703 M |
EBITDA (LTM) |
$ -420 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.